<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01810198</url>
  </required_header>
  <id_info>
    <org_study_id>CONSERVE</org_study_id>
    <nct_id>NCT01810198</nct_id>
  </id_info>
  <brief_title>Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization</brief_title>
  <acronym>CONSERVE</acronym>
  <official_title>Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization: Relation to CardioVascular Outcomes, Cost Effectiveness and Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MDDX LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>MDDX LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effectiveness, safety, and cost efficiency associated with a CCTA-guided
      selective catheterization strategy for stable patients but without known CAD and an American
      Heart Association/ American College of Cardiology Class II indication for non-emergent
      invasive coronary angiography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, randomized controlled multicenter trial to determine the clinical and cost
      effectiveness of a &quot;selective catheterization&quot; strategy versus a &quot;direct catheterization&quot;
      strategy for stable patients with suspected but without known CAD and clinical indication for
      non-emergent invasive coronary angiography. Subjects in the &quot;selective catheterization&quot; arm
      will be followed for a primary endpoint of non-inferiority for rates of major adverse cardiac
      events (MACE) as compare to subjects in the &quot;direct catheterization&quot; strategy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MACE Endpoints</measure>
    <time_frame>1 year</time_frame>
    <description>Death
Non-fatal myocardial infarction
Unstable angina (including new onset angina or those requiring hospitalization, revascularization or that are troponin-positive)
Stroke
Urgent or emergent coronary revascularization
Cardiovascular hospitalization (including for angina, heart failure or other)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional MACE Endpoints</measure>
    <time_frame>1 year</time_frame>
    <description>The primary composite MACE endpoint plus major bleeding.
The primary composite MACE endpoint plus major bleeding or need for urgent/ emergent surgery due to hemorrhage.
The primary composite MACE endpoint plus major bleeding plus need for urgent/ emergent surgery due to hemorrhage plus need for major transfusion.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Economic</measure>
    <time_frame>1 year</time_frame>
    <description>The secondary economic endpoint is within-trial cardiovascular costs*.
*Costs will include index- and downstream CAD-related costs related to diagnostic testing, medications, hospitalizations, emergency department visits, outpatient visits, and coronary revascularizations. (Costs will also include non-CAD-related but test related costs.)</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Safety Endpoint</measure>
    <time_frame>1 year</time_frame>
    <description>The secondary safety endpoint will be rates of serious test-related complications*.
*Serious test-related complications will include contrast-induced nephropathy, hematoma requiring transfusion, arteriovenous fistula, aneurysm formation, retroperitoneal bleed, arterial dissection and any surgery for test-related complications and cumulative CAD test-related effective biological radiation dose.</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1 year</time_frame>
    <description>The tertiary endpoint will be general and angina-specific quality of life, as measured by the EQ-5D Health Survey and Seattle Angina Questionnaire, respectively.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1631</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Cardiac CT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who undergo Cardiac CT (instead of Invasive Coronary Angiography)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Invasive Coronary Angiography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients did not undergo Cardiac CT, went straight to Invasive Coronary Angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac CT</intervention_name>
    <description>Perform a non-invasive Cardiac CT Angiogram</description>
    <arm_group_label>Cardiac CT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Invasive Coronary Angiography</intervention_name>
    <description>Patient undergoes Invasive Coronary Angiography</description>
    <arm_group_label>Invasive Coronary Angiography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          1. Age &gt;18 years

          2. Patients providing written informed consent

          3. Scheduled to undergo clinically-indicated non-emergent invasive coronary angiography
             with an ACC/AHA Class II indication

        EXCLUSION CRITERIA

          1. Known CAD (myocardial infarction, PCI, CABG)

          2. ACC/AHA Class I or III indication for ICA

          3. Non-cardiac illness with life expectancy &lt;2 years

          4. Inability to provide written informed consent

          5. Concomitant participation in another clinical trial in which subject is subject to
             investigational drug or device

          6. Pregnant women

          7. Allergy to iodinated contrast agent

          8. Serum creatinine ≥1.5 mg/dl or Glomerular Filtration Rate &lt;30 ml/min

          9. Uncontrolled Baseline irregular heart rhythm (e.g., atrial fibrillation, etc.)

         10. Heart rate ≥100 beats per minute

        12) Systolic blood pressure ≤90 mm Hg 13) Contraindications to β blockers or nitroglycerin
        14) Known complex congenital heart disease 15) Body mass index &gt;35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Min, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cornell Weill Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dan Gebow, PhD</last_name>
    <role>Study Director</role>
    <affiliation>MDDX LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyuk-Jae Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quanta Diagnostico Nuclear, Curitiba-PR</name>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FACTS</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Monzino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>South Korea</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gangneung Asan Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea university, Guro hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeongnam University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology Warsaw</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>India</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2013</study_first_submitted>
  <study_first_submitted_qc>March 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2013</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Cardiac CT</keyword>
  <keyword>Catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

